RecruitingNot applicableNCT06268496
Efficacy and Tolerability of the Tested Formula After 3 Months in Treatment of Facial Hyperpigmentation of 3 Origins
Studying Disorder of melanin metabolism
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Cosmetique Active International
- Principal Investigator
- Sergio SchalkaMedcin Instituto da Pele Ltda
- Intervention
- serum formula 2039125 03(other)
- Enrollment
- 60 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2024 – 2024
Study locations (1)
- Medcin Instituto da Pele Ltda, Osasco, Brazil
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06268496 on ClinicalTrials.govOther trials for Disorder of melanin metabolism
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07402720Clinical Effectiveness Of Polishing Brush Compared To Ceramic Soft Tissue Trimming Bur In Gingival DepigmentationCairo University
- ENROLLING BY INVITATIONNANCT07195539CO2 Fractional Laser With Tranexamic Acid As An Effective Tool For Post Burn Hyperpigmentation.King Edward Medical University
- RECRUITINGNANCT06491615National Ophthalmic Genotyping and Phenotyping Network (eyeGENE (Registered Trademark)), Stage 3 - Expansion of DNA and Data Repositories for Rare Inherited Ophthalmic DiseasesNational Eye Institute (NEI)
- RECRUITINGNCT06138509Peripheral Serotonin and AlbinismAssistance Publique - Hôpitaux de Paris